{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:00:45Z","timestamp":1771840845507,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jaci.2022.03.023","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T11:11:24Z","timestamp":1649329884000},"page":"12-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Rapid progress in our understanding of COVID-19 vaccine allergy: A\u00a0cause for optimism, not hesitancy"],"prefix":"10.1016","volume":"150","author":[{"given":"Aleena","family":"Banerji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison E.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly G.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Cosby A.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.03.023_bib1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2022.03.023_bib2","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/jama.2021.3976","article-title":"Acute allergic reactions to mRNA COVID-19 vaccines","volume":"325","author":"Blumenthal","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2022.03.023_bib3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaip.2020.12.047","article-title":"mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach","volume":"9","author":"Banerji","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib4","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jaip.2021.03.053","article-title":"COVID-19 vaccination in patients with reported allergic reactions: updated evidence and suggested approach","volume":"9","author":"Banerji","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib5","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1016\/j.jaip.2021.06.010","article-title":"First-dose mRNA COVID-19 vaccine allergic reactions: limited role for excipient skin testing","volume":"9","author":"Wolfson","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib6","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.jaip.2021.06.006","article-title":"The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach","volume":"9","author":"Greenhawt","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jaip.2021.11.021","article-title":"Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: a case series","volume":"10","author":"Picard","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib8","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/jamainternmed.2021.3779","article-title":"Safety evaluation of the second dose of messenger RNA COVID-19 vaccines in patients with immediate reactions to the first dose","volume":"181","author":"Krantz","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaci.2022.03.023_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22255","article-title":"Prevalence of allergic reactions after Pfizer-BioNTech COVID-19 vaccination among adults with high allergy risk","volume":"4","author":"Shavit","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaci.2022.03.023_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25524","article-title":"Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system","volume":"4","author":"Warren","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaci.2022.03.023_bib11","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1016\/j.jaip.2021.06.050","article-title":"Single-dose yellow fever vaccination is well tolerated in egg-allergic children despite positive intradermal test to the vaccine","volume":"9","author":"B\u00e9dard","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.anai.2021.11.017","article-title":"Emergency department visits for vaccine-related severe allergic reactions among US adults: 2006-2018","volume":"128","author":"Arroyo","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2022.03.023_bib13","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1111\/all.14958","article-title":"Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: don\u2019t give up on the second dose","volume":"76","author":"Krantz","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.03.023_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaip.2021.12.021","article-title":"Population-based incidence, severity, and risk factors associated with treated acute-onset COVID-19 mRNA vaccination-associated hypersensitivity reactions","volume":"10","author":"Macy","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJMra2035343","article-title":"Maintaining safety with SARS-CoV-2 vaccines","volume":"384","author":"Castells","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.03.023_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2021.715844","article-title":"Anaphylaxis to Pfizer\/BioNTech mRNA COVID-19 vaccine in a patient with clinically confirmed PEG allergy","volume":"2","author":"McSweeney","year":"2021","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaci.2022.03.023_bib17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaip.2021.12.025","article-title":"Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy","volume":"10","author":"Bruusgaard-Mouritsen","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jaip.2021.09.051","article-title":"mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase","volume":"10","author":"Koo","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jaip.2021.11.025","article-title":"The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: a single institution experience","volume":"10","author":"Rush","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29295","article-title":"Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase","volume":"68","author":"Mark","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaci.2022.03.023_bib21","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/all.15178","article-title":"COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy","volume":"77","author":"Banerji","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.03.023_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2022.5247","article-title":"Urticaria 12 days after COVID-19 mRNA booster vaccination","author":"Wolfson","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2022.03.023_bib23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMc2119358","article-title":"Third BNT162b2 vaccination neutralization of SARS-CoV-2 Omicron infection","volume":"386","author":"Nemet","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.03.023_bib24","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jaci.2021.04.002","article-title":"Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines","volume":"147","author":"Risma","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.03.023_bib25","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jaip.2020.11.011","article-title":"Anti-PEG IgE in anaphylaxis associated with polyethylene glycol","volume":"9","author":"Zhou","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib26","article-title":"Chronic spontaneous urticaria after COVID-19 vaccine","volume":"13","author":"Thomas","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jaci.2022.03.023_bib27","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/healthcare9091144","article-title":"COVID-19 disease leading to chronic spontaneous urticaria exacerbation: a Romanian retrospective study","volume":"9","author":"Muntean","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.jaci.2022.03.023_bib28","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jaip.2018.12.003","article-title":"Immediate hypersensitivity to polyethylene glycols and polysorbates: more common than we have recognized","volume":"7","author":"Stone","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib29","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jaip.2019.12.041","article-title":"Anaphylaxis to PEGylated liposomal echocardiogram contrast in a patient with IgE-mediated macrogol allergy","volume":"8","author":"Krantz","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.023_bib30","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.jaip.2021.03.002","article-title":"Hidden dangers: recognizing excipients as potential causes of drug and vaccine hypersensitivity reactions","volume":"9","author":"Caballero","year":"2021","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922004456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922004456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:35:05Z","timestamp":1758792905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922004456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0091674922004456"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.03.023","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid progress in our understanding of COVID-19 vaccine allergy: A\u00a0cause for optimism, not hesitancy","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}